Hangzhou Proprium Biotech Co. Ltd. is a leading diagnostic company with proprietary products for detecting and monitoring liver disease
Hangzhou Proprium Biotech Co. Ltd. (Proprium) is a leading diagnostic company in the field of liver diseases with several proprietary products for detecting and monitoring liver fibrosis (cirrhosis) and liver cancer. In addition, it has diagnostic products for cardiovascular diseases. Proprium is also developing several diagnostic tests for other common types of cancers and personalized medicine. Its mission is to lead the innovation for the diagnosis and management of liver diseases, cardiovascular diseases and cancers, and to reduce the burden of liver diseases, cardiovascular diseases and cancers.
Founded and led by a team of academic and industrial leaders in research, diagnostic and commercialization, Proprium has products approved by the Chinese FDA. Furthermore, its products also have European Union’s CE mark certificates for distributing in CE marking countries.
To date, the company has raised capital from strategic investors. We are now seeking to raise additional funds to expand our business and to expedite the sales and distributions of our products.
If you are interested in learning more about investment opportunities with Hangzhou Proprium Biotech Co. Ltd, please contact: email@example.com